Produkty 133647-94-6

CAS 133647-94-6 występuje w naszej ofercie pod nazwami: Neocarraoctaose-4¹,4³,4âµ,4â·-tetra-O-sulfate sodium, Neocarraoctaose 41,43,45,47-tetrasulfate (tetrasodium), Neocarraoctaose-41,43,45,47-tetra-O-sulf, ate sodium, 2 mg, Neocarraoctaose-41,43,45,47-tetra-O-sulf, ate sodium, 5 mg, Neocarraoctaose-41,43,45,47-tetra-O-sulf, ate sodium, 10 mg. Oferty producentów: Biosynth, MedChemExpress, Roth. Dostępne opakowania: 5mg, 2mg, 10mg, 50mg, 25mg, Get quote.

Neocarraoctaose-4¹,4³,4âµ,4â·-tetra-O-sulfate sodium
Biosynth
  • opakowanie: 5mg, 2mg, 10mg, 50mg
  • Warianty: 5
Zobacz produkt
Neocarraoctaose 41,43,45,47-tetrasulfate (tetrasodium)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Neocarraoctaose-41,43,45,47-tetra-O-sulf, ate sodium, 2 mg
Roth
  • opakowanie: 2mg
  • Warianty: 1
od 1175,18
Zobacz produkt
Neocarraoctaose-41,43,45,47-tetra-O-sulf, ate sodium, 5 mg
Roth
  • opakowanie: 5mg
  • Warianty: 1
od 2005,84
Zobacz produkt
Neocarraoctaose-41,43,45,47-tetra-O-sulf, ate sodium, 10 mg
Roth
  • opakowanie: 10mg
  • Warianty: 1
od 3280,13
Zobacz produkt
Neocarraoctaose-41,43,45,47-tetra-O-sulf, ate sodium, 25 mg
Roth
  • opakowanie: 25mg
  • Warianty: 1
od 5262,36
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

Tetrasodium;[(2R,3S,4R,5R,6S)-4-[[(1R,3R,4R,5S,8S)-4,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-6-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(3R,4R,5S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] sulfate (CAS 133647-94-6) to związek chemiczny o wzorze sumarycznym C48H70Na4O49S4 i masie molowej 1651.3 g/mol. Nazwa systematyczna IUPAC: tetrasodium;[(2R,3S,4R,5R,6S)-4-[[(1R,3R,4R,5S,8S)-4,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-6-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(3R,4R,5S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] sulfate. InChIKey: QVAKGEVIXLNPPV-CQWLXSKTSA-J.

Dane identyfikacyjne
Wzór sumarycznyC48H70Na4O49S4
Masa molowa1651.3 g/mol
Nazwa IUPACtetrasodium;[(2R,3S,4R,5R,6S)-4-[[(1R,3R,4R,5S,8S)-4,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-6-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(3R,4R,5S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] sulfate
InChIKeyQVAKGEVIXLNPPV-CQWLXSKTSA-J
SMILESC1[C@@H]2[C@@H]([C@H](O1)[C@H]([C@H](O2)O[C@@H]3[C@H]([C@@H](O[C@@H]([C@@H]3OS(=O)(=O)[O-])CO)O[C@H]4[C@H]5CO[C@@H]4[C@H]([C@H](O5)O[C@@H]6[C@H]([C@@H](O[C@@H]([C@@H]6OS(=O)(=O)[O-])CO)O[C@H]7[C@H]8CO[C@@H]7[C@H]([C@H](O8)O[C@@H]9[C@H]([C@@H](O[C@@H]([C@@H]9OS(=O)(=O)[O-])CO)O[C@H]1[C@H]2CO[C@@H]1[C@H]([C@H](O2)O[C@H]1[C@H]([C@H](OC([C@@H]1O)O)CO)OS(=O)(=O)[O-])O)O)O)O)O)O)O)O.[Na+].[Na+].[Na+].[Na+]

Dane obliczone przez PubChem (NCBI)

Synonimy: Neocarraoctaose 41,43,45,47-tetrasulfate tetrasodium salt, C48H70Na4O49S4, Neocarraoctaose-4(1),4(3),4?,4?-tetra-O-sulfate sodium, Neocarraoctaose 41,43,45,47-tetrasulfate tetrasodium salt, >=95%